Clinical trial Recruiting at 1 site Interventional Ages 40 to 80

Genicular Artery Embolization for Knee Osteoarthritis

Official title: Genicular Artery Embolization for Patients With Mild-To-Moderate Knee Osteoarthritis

Run by Northwestern University · NCT07537153 · Data updated 2026-11-12

This study tests whether Genicular Artery Embolization can relieve knee pain in adults with mild-to-moderate knee osteoarthritis who have tried standard treatments.

Quick facts

Study typeInterventional
Ages40 Years to 80 Years
SexAll
Enrollment15 (estimated)
SponsorNorthwestern University
Academic / other
Locations1 site (Chicago, Illinois)
StatusRecruiting
StartedJuly 10, 2026
Main results expectedApril 10, 2028
Study endsApril 10, 2031
Registry record updatedJuly 14, 2026
Trial IDNCT07537153 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 40-80 with mild-to-moderate knee OA (KL grade 2-3) and pain ≥5/10 who have failed at least 3 months of conservative therapy and can commit to follow-up.

Probably not a fit

Patients with severe OA (KL 4), inflammatory arthritis, prior knee replacement in the study knee, or those at high risk from angiography may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study evaluates the safety and effectiveness of Genicular Artery Embolization (GAE) using Embosphere Microspheres for knee osteoarthritis. Participants aged 40-80 with Kellgren-Lawrence grade 2-3 OA and meaningful knee pain will undergo GAE and be followed for approximately three years, including a screening visit, the procedure, and six follow-up visits. The study collects medical history, imaging, and pain questionnaires to assess outcomes while monitoring for adverse events. Eligibility requires radiographic OA severity, adequate pain, prior conservative therapy, and ability to comply with follow-up. Exclusion criteria include inflammatory arthritis, prior knee arthroplasty in the affected knee, significant kidney dysfunction, contrast allergy, infection, pregnancy, and other risks that could affect participation.

Why it matters

Potential benefit: If successful, GAE could reduce knee pain and improve function for people with knee OA who have not responded to conservative care.

How similar studies have gone: Previous studies of GAE in knee OA have shown potential pain reduction, but large randomized data are still emerging, making this an area with growing but not yet definitive evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 40-80 years
* Mild-to-moderate knee OA as determined by radiographs demonstrating Kellgren- Lawrence grade 2-3
* Self-reported pain of at least 5/10 VAS questionnaire
* Failure of conservative therapy, such as pain medications, for at least 3 months
* Patient must understand and sign the informed consent
* Patient can comply with the proposed follow-up schedule
* Patient can follow the post-operative management

Exclusion Criteria:

* History of rheumatoid arthritis
* Renal insufficiency precluding angiography (GFR \< 50 mL/min)
* Irreversible coagulopathy
* Previous knee arthroplasty on the intended knee
* Existing knee joint infection
* Kellgren-Lawrence grade 1 or 4
* Severe atherosclerosis as manifest by claudication and/or diminished peripheral pulses
* Life expectancy \< 6 months
* Infectious arthritis
* Allergy to iodinated contrast resulting in anaphylaxis
* Pregnant or interested in becoming pregnant three months from the date of the GAE procedure
* Involved in litigation or worker's compensation claims

Where it's running

  • Northwestern University
    Chicago, Illinois, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.